Carbs and kids: new study reveals how diet impacts diabetes control with smart pumps
NCT ID NCT05866900
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at 347 children and teens with type 1 diabetes who use the Medtronic MiniMed 780G insulin pump. Researchers tracked how much carbohydrate they ate each day and measured their blood sugar control over time. The goal was to understand the link between daily carb intake and glucose levels in real-world settings.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this study could help doctors give better dietary advice to children with type 1 diabetes using automated insulin pumps.
- What could go wrong
- This is an observational study, not a treatment trial, so it won't prove cause and effect. Results may not apply to all children or other insulin pump systems.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
347 people
The number who actually took part.
- Started
-
May 2023
- Finished
-
Oct 2023
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Participants will be recruited from electronical records of two Pediatric Diabetes departments located in Slovenia and Italy
- Ages
-
7 to 18 years
- Sex
-
Anyone
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Patients with type 1 diabetes * Patients aged 7-18 years * Patients using Medtronic MiniMed 780G with SmartGuard activated * Patients whose informed consent has been obtained * \>70% CGM data during observational period Exclusion Criteria: * Patients with partial clinical remission according to the Hvidovre Study Group definition * Concomitant treatment with steroids or other drugs known to interfere with blood glucose levels * Previous diagnosis of psychological or eating disorders
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Diabetes mellitus, type 1 are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
1Department of Human Pathology in Adult and Developmental Age "Gaetano Barresi," University ofMessina
Messina, Italy
-
Medical Faculty - University of Ljubljana
Ljubljana, 1000, Slovenia
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a glucose app that predicts lows calm diabetes fears?
- Could type 1 diabetes hide liver problems in children?
- Can a Weight-Loss drug slow stomach emptying in type 1 diabetes?
- Can pressurized oxygen tame blood sugar spikes?
- Could a virtual life-coach program help young adults tame type 1 diabetes?
- Can Real-World data improve diabetes care in pregnancy?